Skip to main content
. 2016 Sep 15;65(12):1465–1476. doi: 10.1007/s00262-016-1896-4

Fig. 3.

Fig. 3

Influence of MIF inhibitors on tumour cell migration. A204 (a), RD (b), Rh30 (c), and RMS33-2 (d) cells were treated with the MIF inhibitors Ant.III (25 µM), Ant.V (25 µM), ISO-1 (25 µM), and SF (3 µM) as well as anti-MIF antibodies (2 µg/ml). At the indicated time points, migration was evaluated in relation to untreated controls (100%). Impaired migration of tumour cells was obvious after 5 h in some treatments (*)